✓ COA VerifiedIpamorelin
Pentapeptide selective GH secretagogue with high selectivity and minimal effect on prolactin or cortisol.
Browse our full range of research-grade peptides.
✓ COA VerifiedPentapeptide selective GH secretagogue with high selectivity and minimal effect on prolactin or cortisol.
✓ COA VerifiedPentadecapeptide fragment of Body Protection Compound. Studied for cytoprotective effects, wound healing, angiogenesis, and gastrointestinal tract repair research.
✓ COA VerifiedSynthetic tetrapeptide derived from Epithalamin. Studied for telomerase activation, pineal gland function, melatonin regulation, and longevity pathway research. Supplied in a 10ml vial.
✓ COA VerifiedMitochondrial-derived peptide studied for metabolic regulation, insulin sensitivity, and cellular energy homeostasis pathways.
✓ COA VerifiedLong-acting amylin receptor agonist frequently studied alongside GLP-1 compounds. Investigated for appetite regulation and metabolic research.
✓ COA VerifiedHeptapeptide analogue of tuftsin studied for cognitive enhancement, anxiety modulation, and immune function research.

GHRH analogue with extended half-life. Studied for sustained growth hormone secretion, body composition, and anti-aging research.

Pre-blended Ipamorelin and CJC-1295 (no DAC). Convenient single-vial format for GH-axis research, combining a selective GH secretagogue with an extended-half-life GHRH analogue. Studied for body composition, recovery, and growth hormone pulse research.

Alanyl-L-histidyl-L-lysine copper complex. Tripeptide copper peptide studied for hair follicle stimulation, scalp health, and dermal research. Smaller-molecule companion to GHK-Cu commonly investigated in hair growth pathway studies.

Pre-blended BPC-157 and TB-500 recovery stack in a single vial (10mg each, 20mg total). Synergistic combination studied for accelerated tissue repair, angiogenesis, anti-inflammatory pathways, and musculoskeletal recovery research.

Delta sleep-inducing peptide. Nonapeptide studied for sleep regulation, neuroendocrine modulation, and stress response research.

Glycyl-L-histidyl-L-lysine copper complex. Naturally occurring copper peptide extensively studied for wound healing, anti-inflammatory pathways, and tissue remodelling research.

A synergistic recovery and tissue-repair research blend. Each vial contains 50mg GHK-Cu, 10mg TB-500, and 10mg BPC-157 — three of the most studied compounds for wound healing, angiogenesis, and cellular regeneration, combined for research convenience.

Our go-to skin and recovery blend in one vial: 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, and 10mg KPV. GHK-Cu brings the copper-peptide collagen research angle, BPC-157 and TB-500 cover tissue repair and recovery pathways, and KPV rounds it out with anti-inflammatory research interest. Built so researchers studying skin, recovery, and inflammation together do not need four separate vials.

Bigger format of our 5-Amino-1MQ, same NNMT inhibitor, fewer vials per protocol. Studied for blocking nicotinamide N-methyltransferase, an enzyme linked to fat storage and NAD+ depletion, making it a popular pairing in fat metabolism and body composition research.

L-Carnitine — an amino acid derivative central to fatty-acid transport and cellular energy metabolism. Studied for fat oxidation, exercise performance, and metabolic research. Supplied as lyophilized powder for reconstitution.

Cyclic alpha-MSH analogue studied for melanogenesis, sexual function research, and appetite regulation pathways.

Bremelanotide — a cyclic heptapeptide melanocortin receptor agonist. Studied for sexual dysfunction research and central nervous system melanocortin pathway investigation.

Triple receptor agonist acting on GLP-1, GIP, and glucagon receptors simultaneously. One of the most studied next-generation metabolic peptides.

Triple receptor agonist acting on GLP-1, GIP, and glucagon receptors simultaneously. Entry-level format for researchers beginning GLP-1/GIP/glucagon agonism studies.

Dual GIP and GLP-1 receptor agonist. Our largest Tirzepatide format — the best value per mg for extended metabolic research protocols that need larger quantities.

Dual GIP and GLP-1 receptor agonist. Best value format for extended research protocols requiring larger quantities.

ACTH(4-7) Pro-Gly-Pro analogue studied for neuroprotection, cognitive enhancement, and neurological function research.
✓ COA VerifiedTriple receptor agonist — GLP-1, GIP, and glucagon. Best value format for extended research protocols requiring larger quantities.

Synthetic analogue of growth hormone-releasing hormone (GHRH). Studied for its role in GH secretion, body composition research, and visceral adipose tissue regulation.

USP-grade sterile water preserved with 0.9% benzyl alcohol for safe multi-dose use. The standard reconstitution solution for lyophilized peptide research compounds. Prevents microbial growth across multiple vial punctures.

Endogenous neuropeptide and potent activator of GnRH neurons. Studied for reproductive endocrinology research, LH surge modulation, and hypothalamic-pituitary axis investigation.

Reduced glutathione (GSH) — the body's master antioxidant tripeptide. Studied for oxidative stress reduction, cellular detoxification pathways, and skin/complexion research. Supplied as lyophilized powder for reconstitution.

Nicotinamide adenine dinucleotide. Studied for cellular energy metabolism, DNA repair, sirtuin activation, and longevity pathways.

Same SS-31 compound as our 10mg vial, just more peptide per vial for researchers running longer mitochondrial studies without reconstituting every few days. Mitochondria-targeted antioxidant tetrapeptide studied for oxidative stress reduction, mitochondrial protection, and cellular energy research.

Szeto-Schiller peptide — a mitochondria-targeted antioxidant tetrapeptide. Studied for mitochondrial protection, oxidative stress reduction, and cellular energy optimization.

5-amino-1-methylquinolinium - a selective NNMT (nicotinamide N-methyltransferase) inhibitor. Studied for adipocyte energy expenditure, lipid metabolism, and NAD+ pathway research.

Triple receptor agonist acting on GLP-1, GIP, and glucagon receptors simultaneously. A mid-range format for ongoing metabolic research protocols.
* Product images for reference only. Actual vial labels may vary slightly between batches in design or formatting; compound and dosage remain identical to listing.